-+ 0.00%
-+ 0.00%
-+ 0.00%

Nektar grants 36,000 inducement stock options priced at $64.84 per share

PUBT·07/24/2026 20:15:29
Listen to the news
Nektar grants 36,000 inducement stock options priced at $64.84 per share
  • Nektar Therapeutics granted non-qualified stock options covering 36,000 shares to 23 newly hired employees on July 20, 2026.
  • Options were issued under the company’s 2025 Inducement Plan, adopted Nov. 6, 2025.
  • Exercise price set at $64.84 per share, matching the July 20 closing price.
  • Options carry an eight-year term; vesting runs four years with 25% after one year, then monthly over three years.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Nektar Therapeutics published the original content used to generate this news brief via PR Newswire (Ref. ID: 202607241615PR_NEWS_USPR_____SF11541) on July 24, 2026, and is solely responsible for the information contained therein.